SCHEMBL3024969

SCHEMBL3024969

C=CCO/N=C(/C)c1ccc(-c2ccccc2NC(=O)c2c(C)nn(C)c2F)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
LMNA P02545 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
S1PR1 P21453 2/20 0.34
HSD17B10 Q99714 3/20 0.34
CHRM3 P20309 4/20 0.34
TSHR P16473 4/20 0.34
MAPT P10636 3/20 0.34
USP2 O75604 1/20 0.34
POLB P06746 1/20 0.34
HTT P42858 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
KDM4E B2RXH2 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
LCK P06239 1/20 0.32
CSF1R P07333 1/20 0.32
KIT P10721 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13215212 1.00 ALDH1A1 (0.37) ALDH1A1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL3024971 1.00 ALDH1A1 (0.37) ALDH1A1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL14266421 0.91 ALDH1A1 (0.40) ALDH1A1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL14266408 0.88 NR3C1 (0.39) ALDH1A1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL5111904 0.88 ALDH1A1 (0.42) ALDH1A1MEN1KMT2ALMNAHSD17B10
SCHEMBL5111902 0.88 ALDH1A1 (0.42) ALDH1A1MEN1KMT2ALMNAHSD17B10
SCHEMBL14266444 0.87 MEN1 (0.38) ALDH1A1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL6270547 0.87 CHRM3 (0.35) LMNASMN1; SMN2S1PR1CHRM3LCK
SCHEMBL14266435 0.86 NR3C1 (0.41) ALDH1A1MEN1KMT2ASMN1; SMN2S1PR1
SCHEMBL13215922 0.86 ALDH1A1 (0.38) ALDH1A1MEN1KMT2ALMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100216849-A1 BIPHENYLCARBOXAMIDES DUNKEL RALF 2010-08-26 US disclosed
US-7728019-B2 Biphenylcarboxamides BAYER CROPSCIENCE AG (DE) 2010-06-01 US disclosed
US-20080085924-A1 Biphenylcaboxamides BAYER CROPSCINCE AG (DE) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085924-A1 Biphenylcaboxamides AHR, Q6ZSR9, DDT ALDH1A1 415/4885MEN1 1392/4885KMT2A 177/4885
US-20100216849-A1 BIPHENYLCARBOXAMIDES AHR, DDT, MRPL21 ALDH1A1 478/4885MEN1 1557/4885KMT2A 182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.